Market AnalysisBiocon Share Worth Rises on USFDA Approval By StockWaves Last updated: March 5, 2025 0 Min Read SHARE Biocon’s share worth noticed a major improve following USFDA approval for Lenalidomide Capsules.> Sign Up For Daily NewsletterBe keep up! Get the latest breaking news delivered straight to your inbox. Leave this field empty if you're human: By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. Share This Article Facebook Twitter Copy Link Print Previous Article Earnings Scheduled For March 5, 2025 – ACRES Industrial Realty (NYSE:ACR), Allient (NASDAQ:ALNT) Next Article Qualcomm CEO says its new modem creates a ‘enormous delta’ with Apple Leave a commentLeave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment. FacebookLikeTwitterFollowPinterestPinInstagramFollowSubscribe NowSubscribe to our newsletter to get our newest articles instantly! Leave this field empty if you're human: Most Popular Outdated Tax Regime vs New Tax Regime March 18, 2025 Shares to Purchase | Neeraj Dewan’s tackle Market Volatility: Dangers & Alternatives – Market Overview March 18, 2025 Astronauts Butch Wilmore, Suni Williams returning to Earth on SpaceX ship March 18, 2025 Vedanta share value jumps 3% after THIS letter by Chairman Anil Agarwal March 18, 2025 Nationwide Means Cum Benefit Scholarship (NMMS) Examination – Defined March 18, 2025
